Stock 688658 YOUCARE PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Youcare Pharmaceutical Group Co., Ltd.

Equities

688658

CNE100005XQ2

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
16.86 CNY -1.17% Intraday chart for Youcare Pharmaceutical Group Co., Ltd. -3.93% -19.18%
04-29 Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-09 Youcare Pharma Gets Nod for Registration of Gastric Drug MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Youcare Pharma Gets Nod for Registration of Gastric Drug
MT
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Youcare Pharmaceutical’s Antibiotic Passes Generic Drug Evaluation
MT
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023.
CI
Certain A Shares of Youcare Pharmaceutical Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-DEC-2023.
CI
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023.
CI
Youcare Pharmaceutical Group Co., Ltd.(XSSC:688658) added to S&P Global BMI Index
CI
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Youcare Pharma's Cefoperazone Sodium Sulbactam Sodium for Injection Passes Regulatory Evaluation
MT
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023.
CI
Youcare Pharma to Repurchase Up to 200 Million Yuan Shares
MT
Youcare Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
CI
Youcare Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.
CI
Youcare Pharma’s Inhaled COVID-19 Drug Candidate Cleared For Clinical Trial in Australia
MT
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688658 Stock
  4. News Youcare Pharmaceutical Group Co., Ltd.